MND – UBS rates the stock as Neutral

Monadelphous has guided to sales being up around 10% in the first half versus the prior half, better than UBS anticipated. The stronger resumption in activity is reflected in improved staffing levels which have increased by around 20% since June.

UBS assumes a gradual recovery in maintenance revenue in FY21 while pressure on the oil & gas sector is likely to continue.

The AGM provided no further details on the dispute with Rio Tinto ((RIO)). UBS retains a Neutral rating and raises the target to $12.10 from $10.00.

Sector: Capital Goods.

Target price is $12.10.Current Price is $12.28. Difference: ($0.18) – (brackets indicate current price is over target). If MND meets the UBS target it will return approximately -1% (excluding dividends, fees and charges – negative figures indicate an expected loss).

About Broker News

FNArena's Australian Broker Call, is your daily news report on the latest recommendation, valuation, forecast and opinions recently published by Stockbrokers.

View more articles by Broker News →